Peter Altman - 19 Sep 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
19 Sep 2025
Transactions value $
$60,000
Form type
4
Filing time
23 Sep 2025, 09:00:09 UTC
Previous filing
25 Aug 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Altman Peter President and CEO, Director C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE /s/ David McClung, by power of attorney 23 Sep 2025 0001647542

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $60K +48K +28.44% $1.25 217K 19 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Warrant (right to buy) Purchase +48K +50.2% 144K 19 Sep 2025 Common Stock 48K $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.